Drug-susceptibility testing in tuberculosis: Methods and reliability of results

European Respiratory Journal

Volumn 25, Issue 3, 2005, Pages 564-569

  Kim, S J ^a,b  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b Intl Union Against TB/Lung Disease   (South Korea)

Author keywords

Drug resistance; Drug susceptibility testing; Tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; CULTURE MEDIUM; GENE MUTATION; HUMAN; IN VITRO STUDY; INCIDENCE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; STANDARDIZATION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS;

EID: 14744305557     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00111304     Document Type: Article

References (28)

1. World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (WHO/TB/97.229). Geneva, World Health Organization Document, 1997.
2. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 2: prevalence and trends. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (WHO/CDC/TB/2000.278). Geneva, World Health Organization document, 2000.
3. World Health Organization. Anti-tuberculosis drug resistance in the world. Third global report. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (WHO/CDC/TB/2004). Geneva, World Health Organization document, 2004 (In press).
4. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
5. Kent TK, Kubica GP. Public health mycobacteriology. A guide for the level III laboratory. Atlanta, Center for Disease Control, 1985.
6. Hawkins JE, Wallace RJ Jr, Brown BA. Antibacterial drug susceptibility tests: mycobacteria. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadommy HJ, eds. Manual of clinical microbiology. 5th Edn. Washington DC, American Society for Microbiology, 1991; pp. 1138-1152.
7. Diaz-Infantes MS, Ruiz-Serrano MJ, Martinez-Sanchez L, et al. Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 1988-1989.
8. Bemer P, Palicova FR, Rusch-Gerdes S, Drugeon HB, Pfyffer GE. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 150-154.
9. Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemotherap 2002; 46: 2720-2722.
10. Abate G, Mshana RN, Miörner H. Evaluation of a colorimetric assay based on 3-(4,5-dimethyl-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998; 2: 1011-1016.
11. Riska PF, Su Y, Bardarov S, et al. Rapid film-based determination of antibiotic susceptibility of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx box. J Clin Mirobiol 1999; 37: 1144-1149.
12. Gali N, Dominguez J, Blanco S, et al. Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 2003; 41: 2647-2649.
13. Drowart A, Cambiaso CL, Huygen K, et al. Detection of rifampicin and isoniazid resistance of Mycobacterium tuberculosis strains by particle counting immunoassay. Int J Tuberc Lung Dis 1997; 1: 284-288.
14. Lebrun L, Gönüllü N, Boutros N, et al. Use of INNO-LIPA assay for rapid identification of mycobacteria. Diagn Microbiol Infect Dis 2003; 46: 151-153.
15. El-Haji HH, Marras SAE, Tyagi S, Kramer FR, Alland D. Detection of rifampicin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001; 39: 4131-4137.
16. Kim BJ, Lee KH, Park BN, et al. Detection of rifampicin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing. J Clin Microbiol 2001; 39: 2610-2617.
17. Lin YP, Behr MA, Small PM, Kurn N. Genotypic determination of Mycobacterium tuberculosis antibiotic resistance using a novel mutation detection method, the branch migration inhibition M. tuberculosis antibiotic resistance test. J Clin Microbiol 2000; 38: 3656-3662.
18. Mokrousov I, Otten T, Filipenko M, et al. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay testing katG codon 315 variation. J Clin Microbiol 2002; 40: 2509-2512.
19. Torres MJ, Criado A, Palomares JC, Aznar J. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 3194-3199.
20. Van Der Zanden AG, Te Koppele-Vize EM, Vijaya Bhanu N, Van Soolingen D, Schouls LM. Use of DNA extracts from Ziehl-Neelsen-stained slides from molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 1101-1108.
21. Pfyffer GE, Bonato DA, Ebrahimzadeh A, et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 1999; 37: 3179-3186.
22. Lefford MJ, Mitchison DA. Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide. Tubercle 1966; 47: 250-262.
23. Korean Institute of Tuberculosis, Korean National Tuberculosis Association. Drug susceptibility testing on mycobacteria by the proportion method. Research report, 1994.
24. Mitchison DA. What is drug resistance? Tubercle 1969; 50: 44-47.
25. Kim SJ, Espinal MA, Abe C, et al. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis 2004; 8: 1157-1158.
26. Canetti G. The J. Burns Amberson lecture: present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 1966; 92: 687-703.
27. Iwainsky H. Mode of action, biotransformation and pharmacokinetics of antituberculosis drugs in animal and man. In: Bartmann K, ed. Antituberculosis drugs. New York, Springer-Verlag, 1988; pp. 399-553.
28. Heifets LB. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, CRC Press, 1991.